About Vibrent
Vibrent is a company based in Fairfax (United States) founded in 2009 by Praduman Jain. The company has 34 employees as of July 31, 2025. Vibrent offers products and services including Research Cloud, eConsent, and Dashboards/Insights. Vibrent operates in a competitive market with competitors including Medidata, Verily, TriNetX, Signant Health and Clinical Ink, among others.
- Headquarter Fairfax, United States
- Employees 34 as on 31 Jul, 2025
- Founders Praduman Jain
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
$10.19 M (USD)39as on Mar 31, 2022
-
Net Profit
$1.26 M (USD)64as on Mar 31, 2022
-
EBITDA
$1.76 M (USD)61as on Mar 31, 2022
-
Latest Funding Round
$39 M (USD), Grant
Sep 08, 2020
- Investors
-
Employee Count
34
as on Jul 31, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vibrent
Vibrent offers a comprehensive portfolio of products and services, including Research Cloud, eConsent, and Dashboards/Insights.
Platform for managing study data and research processes.
Electronic tool for virtual participant consent in trials.
Provides real-time data analysis for research decisions.
People of Vibrent
Unlock access to complete
Funding Insights of Vibrent
Investors in Vibrent
Vibrent has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include NIH.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Drug discovery services are provided to the biopharma sector.
|
Locked | Locked | Locked |
Investor details for Vibrent
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vibrent
Investment portfolio details for Vibrent
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Vibrent
Detailed financials for Vibrent
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vibrent Comparisons
Peer comparison for Vibrent
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Vibrent
Vibrent operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medidata, Verily, TriNetX, Signant Health and Clinical Ink, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
|
|
| Locked | Locked | Locked |
AI-based solutions for health management are provided.
|
|
| Locked | Locked | Locked |
Clinical trial management software is provided for researchers and professionals.
|
|
| Locked | Locked | Locked |
Signant Health is engaged in providing clinical trial technology solutions.
|
|
| Locked | Locked | Locked |
Paperless eSource and patient engagement solutions for clinical trials
|
|
| Locked | Locked | Locked |
Regulatory and ethical review services for clinical research are provided.
|
Detailed competitors of Vibrent
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vibrent
Complete news archive for Vibrent
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vibrent
Vibrent was founded in 2009 and raised its 1st funding round 7 years after it was founded.
Vibrent is headquartered in Fairfax, United States. It is registered at Fairfax, Virginia, United States.
Praduman Jain is the current CEO of Vibrent. They have also founded this company.
As of Jul 31, 2025, the latest employee count at Vibrent is 34.
Annual revenue of Vibrent is $10.19M as on Mar 31, 2022.
Provider of a cloud-based precision medicine platform. It provides an evidence-based technology platform known as Adaptive Platform for Personalized Engagement for longitudinal data collection, engagement, and insights. Specific functionality includes mobile and web apps, interactive informed consent, assessments, surveys, passively sensed data, wearables, and wireless devices data, teachable moments, interventions, reminders, schedules, motivational interviewing, notifications, customized monitoring, feedback loops, coaching, alerts, temporal data integration, visualization, analytics, machine learning and reporting of individual and group level measures and outcomes.
Vibrent offers Research Cloud, eConsent, and Dashboards/Insights.
Vibrent has 1 investor. Key investors include NIH.